These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 477192)

  • 21. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mineralocorticoids, salt and high blood pressure.
    Gómez-Sánchez EP; Zhou M; Gomez-Sanchez CE
    Steroids; 1996 Apr; 61(4):184-8. PubMed ID: 8732997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relative importance of glucocorticoids and mineralocorticoids in the development of adrenal regeneration hypertension in rats.
    Kenyon CJ; Clark SA; Hannah JA; Holloway CD; Ingram MC; Lindop G; Towrie A; Ball SG
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):389-95. PubMed ID: 3019053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertensinogenic potencies of aldosterone and deoxycorticosterone in the rat.
    Komanicky P; Melby JC
    Hypertension; 1982; 4(1):140-5. PubMed ID: 7061121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized rat.
    Perrone RD; Bengele HH; Dale SL; Melby JC; Alexander EA
    Am J Physiol; 1982 May; 242(5):E305-8. PubMed ID: 7081431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between the level of mineralocorticoid arterial hypertension and calcium metabolism in the rat].
    Miss-Pages C; Gairard A
    C R Seances Soc Biol Fil; 1975; 169(3):700-5. PubMed ID: 129220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla.
    Zhang MZ; Hao CM; Breyer MD; Harris RC; McKanna JA
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F509-16. PubMed ID: 12167602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats.
    Carreño JE; Verdugo FJ; Contreras F; Montellano FA; Veloso S; Schalper KA; Sandoval M; Villanueva S; Marusic E; Irarrazabal CE
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1225-31. PubMed ID: 25997821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
    Karatas A; Hegner B; de Windt LJ; Luft FC; Schubert C; Gross V; Akashi YJ; Gürgen D; Kintscher U; da Costa Goncalves AC; Regitz-Zagrosek V; Dragun D
    Hypertension; 2008 Apr; 51(4):1177-83. PubMed ID: 18259006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertensive potency of 18-oxocortisol in the rat.
    Hall CE; Gomez-Sanchez CE
    Hypertension; 1986 Apr; 8(4):317-22. PubMed ID: 3957417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the adrenal medullae in male and female DOCA-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 1998 Jan; 31(1 Pt 2):403-8. PubMed ID: 9453336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response.
    Beswick RA; Zhang H; Marable D; Catravas JD; Hill WD; Webb RC
    Hypertension; 2001 Feb; 37(2 Pt 2):781-6. PubMed ID: 11230373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental hypertension induced by 19-nor-progesterone treatment in the rat.
    Komanicky P; Melby JC
    Endocrinology; 1981 Oct; 109(4):1164-7. PubMed ID: 7285864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The parathyroids and desoxycorticosterone acetate induced arterial hypertension in the rat].
    Berthelot A; Schleiffer R; Gairard A
    Can J Physiol Pharmacol; 1979 Feb; 57(2):157-62. PubMed ID: 546483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
    Campen TJ; Vaughn DA; Fanestil DD
    Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of age on the activity of the renin-angiotensin system in rats with adrenal-regeneration hypertension.
    Pohlová I; Kunes J; Jelínek J
    Physiol Bohemoslov; 1983; 32(5):438-48. PubMed ID: 6359194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension following adrenal enucleation and its absence during desoxycorticosterone treatment in Long-Evans rats.
    Hall CE; Ayachi S; Hall O
    Endocrinology; 1973 Apr; 92(4):1175-81. PubMed ID: 4686314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.